Measures antibodies against 7 groups of proteins and peptides associated with the development of Alzheimer’s disease and other neurodegenerative disorders: brain proteins; growth factors; enteric nerve, enzymes, and neurological peptides; pathogens; chemicals; foods cross-reactive to amyloid-beta; and blood-brain barrier and neurofilaments. Detects Alzheimer's-associated immune reactivity. It helps identify patients at a greater risk of developing Alzheimer's disease or other neurological disorders, identify the early stage of neurodegenerative processes, and monitor the effectiveness of lifestyle modifications for Alzheimer's disease. Developed and published by Aristo Vojdani, PhD, MSc, CLS, known as the father of functional immunology, in 2015, 2018 and 2021.
Hey practitioners! 👋 Join Dr. Elizabeth Boham, MD, MS, RD, a physician and nutritionist who practices Functional Medicine, for an insightful webinar, "Understanding Breast Health & Risk Reduction" on Thursday May 29 at 12 PM EST / 9 AM PST.
In this session, you'll gain insight into how factors like insulin resistance, inflammation, environmental exposures and the microbiome may influence breast tissue health and explore strategies to help support a healthy internal environment and overall cellular wellness. Register now to secure your spot!
.png)
.svg){kind=small}
.svg){kind=small}
